Behavioral motor effects of MK-801 and DNQX parenteral administration in adult cats: Dose-response analysis. Modulatory role of dopaminergic D1 and D2 antagonists on MK-801 induced motor behaviors

Archives Italiennes de Biologie

Volumn 138, Issue 2, 2000, Pages 167-174

  Motles, E ^a   Infante, C ^a   Gonzalez, M ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SULPIRIDE; AMINO ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; DIZOCILPINE MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; N METHYLASPARTIC ACID; QUINOXALINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; ATAXIA; BODY EQUILIBRIUM; CAT; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; FEMALE; MALE; MOTOR DYSFUNCTION; NONHUMAN; ANIMAL; ANIMAL BEHAVIOR; DRUG ANTAGONISM; MOTOR ACTIVITY; SUBCUTANEOUS DRUG ADMINISTRATION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BEHAVIOR, ANIMAL; CATS; DIZOCILPINE MALEATE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; INJECTIONS, SUBCUTANEOUS; MALE; MOTOR ACTIVITY; N-METHYLASPARTATE; QUINOXALINES; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SULPIRIDE;

EID: 0033624961     PISSN: 00039829     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. CARLSSON, M. AND CARLSSON, A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia. Implications for Schizophrenia and Parkinson's disease. Trends Neurosci., 13: 272-276, 1990.
2. CHERAMY, A., ROMO, R., GODEHN, G., BARUCH, P. AND GLOWINSKI, J. In vivo presynaptic control of dopamine release in the caudate nucleus - II. Facilitatory or inhibitory influence of L - Glutamate. Neuroscience, 19: 1081-1090, 1986.
3. COLLINGRIDGE, G.L. AND BLISS, T. V. NMDA receptors, their role in long-term potentiation. Trends Neurosci., 10: 288-293, 1987.
4. DAW, N.W., STEIN, P.S.G. AND FOX, K. The role of NMDA receptor in information processing. Ann. Rev. Neurosci., 16: 207-222, 1993.
5. GILL, R., FOSTER, A.C. AND WOODRUFF, G.N. MK-801 is neuroprotective in gerbils when administered during the post-ischaemic period. Neuroscience, 25: 847-855, 1988.
6. HOLLMANN, M. et al. Cloned glutamate receptors. Ann. Rev. Neurosci., 17: 31-108, 1994.
7. HUNDLEY, G.J., VICKERS, J.C. AND MORRISON, J.H. Cellular and synaptic localization of NMDA and non-NMDA receptor subunits in neocortex: organizations features related to cortical circuity, function and disease. Trends Neurosci., 17: 536-542 1994.
8. IVERSEN, L.L. MK-801 (Dizocilpine maleate)-NMDA receptorantagonist. Rev. Biochem. Inst., 10: 1-4, 1994.
9. KEMP, J.A., FOSTER, A.C. AND WONG, E.H.F. Non-competitive antagonists of excitatory amino-acid receptors. Trends Neurosci., 10: 294-298, 1987.
10. MALENKA, R.C. AND NICOLL, R.A. NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci., 16: 521-526, 1993.
11. MARTINEZ-FONG, D., ROSALES, M.G., GONGORA-ALFARO, J.L., HERNANDEZ, J. AND ACEVES, J. NMDA receptor mediates dopamine release in the striatum of unanesthetized rats as measured by brain microdialysis. Brain Res., 595: 309-315, 1992.
12. MOGHADDAM, B. AND GRUEN, R.J. Do endogenous excitatory aminoacids influence striatal dopamine release? Brain Res., 544: 329-330, 1991.
13. MORELLI, M., FENU, S., PINNA, A. AND DI CHIARA, G. Opposite effects of NMDA receptor blockade on dopaminergic D1-and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with 6-fos expression. J. Pharmac. Exp. Ther., 260: 402-408, 1992.
14. MOTLES, E., GOMEZ, A., TETAS, M. AND GONZALEZ, M. Effects of SCH 23390 and sulpiride on the behaviors evoked by amphetamine and apomorphine in adult cats. Prog. Neuro-Psychopharmacol. & Biol. Psychiat., 17: 1005-1022, 1993.
15. MOTLES, E., MARTINEZ, I., CONCHA, E., MEJIAS, B. AND TORRES, P. Comparative study of the behavioral changes evoked by d-amphetamine and apomorphine in adult cats. Pharmacol. Biochem. Behav., 33: 115-121, 1989.
16. NAKANISHI, S. Molecular diversity of glutamate receptors and implications for brain function. Science, 258: 597-602, 1992.
17. OLNEY, J., PRICE, M., SALLES, S.K., LABRUYERE, J. AND FRIERDICH, G. MK-801 powerfully protects against N-methyl aspartate. Neurotoxicity. Eur. J. Pharmac., 141: 357-361, 1987.
18. PIN, J.P. AND DUVOISIN, R. Review: Neurotransmitter receptors I. The metabotropic glutamate receptors: Structure and functions. Neuropharmacology, 34: 1-26, 1995.
19. ROGAWSKI, M.A. Therapeutic potential of excitatory aminoacid antagonists: Channel blockers and 2,3-benzodiazepines. Trends Pharmac. Sci., 14: 325-331, 1993.
20. RIEDEL, G. Function of metabotropic glutamate receptors in learning and memory. Trends Neurosci., 19: 219-224, 1996.
21. ROTHMAN, S.M. et al. Glutamale and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol., 19: 105-111, 1986.
22. SCHOEPP, D.D. AND CONN, P.J. Metabotropic glutamate receptors in brain function and pathology. Trends Pharmac. Sci., 14: 1320, 1993.